The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats. (Q51765630)

11 April 2018

title

The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats. (English)

1 reference

11 April 2018

author name string

Mohit Khera

1

1 reference

11 April 2018

Timothy B Boone

2

1 reference

11 April 2018

Nilson Salas

3

1 reference

11 April 2018

Mary-Frances Jett

4

1 reference

11 April 2018

George T Somogyi

5

1 reference

11 April 2018

publication date

1 February 2007

1 reference

11 April 2018

published in

BJU International

1 reference

11 April 2018

volume

99

1 reference

11 April 2018

issue

2

1 reference

11 April 2018

page(s)

442-446

1 reference

11 April 2018

Cyclooxygenase-2 protein and prostaglandin E(2) production are up-regulated in a rat bladder inflammation model

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

Prostanoids as local modulators of reflex micturition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

Urine 8-isoprostane F2alpha concentrations in patients with neurogenic bladder due to spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

Increased leukotriene and prostaglandin release, and overactivity in the chronically ischemic bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

The pharmacological treatment of urinary incontinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

Discovery and SAR development of 2-(phenylamino) imidazolines as prostacyclin receptor antagonists [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

Characterization of prostanoid receptor-evoked responses in rat sensory neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

Prostaglandin E2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06615.X

10.1111/J.1464-410X.2007.06615.X

21 January 2018

Identifiers

DOI

1 reference

11 April 2018

PubMed ID

17313428

1 reference

11 April 2018